Endpoints 11 2022: John Carroll's fireside chat with Nobel Prize laureate Phil Sharp (Credit: Michael Last)
September 18, 2023 06:14 AM EDT
Editor's note
Bioregnum

Did I ever tell you the one about the drunk­en biotech awards pro­gram I host­ed at a Chica­go bar?

John Carroll

Editor & Founder

I’ll be head­ed in­to Boston on Wednes­day for this year’s End­points 11. And this year, we have some very in­ter­est­ing plans to cel­e­brate our se­lec­tion …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times